Bioscience company research provides hope to patients and caregivers around the world. The United States drives that innovation and is the global leader when it comes to drug discovery. However, state and federal policies are challenging bioscience companies’ ability to continue to innovate at the same rate. In this conversation, panelists will discuss ways that patient access to new therapies and cures could be limited by policies such as price controls, PDABs, and others.

Patients and caregivers play an important role in shaping policy. In this conversation, panelists will discuss how patients can advocate for innovation by exploring the successes of rare disease policy advocacy. Hear from industry experts and advocates on the engagement process and how the policy discussion can be impacted by your voice.